![(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F319814-1s-15-anhydro-1-c-4-chloro-3-4-ethoxyphenyl-methyl-phenyl-d-glucitol-s-propane-12-diol-1-1-monohydrate.webp&w=3840&q=75)
CAS 960404-48-2
:(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (1:1) monohydrate
Formula:C21H25ClO6·C3H8O2·H2O
InChI:InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1
InChI key:InChIKey=GOADIQFWSVMMRJ-UPGAGZFNSA-N
SMILES:O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2.[C@@H](CO)(C)O.O
Synonyms:- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-<span class="text-smallcaps">D</span>-glucitol (S)-propane-1,2-diol (1:1) monohydrate
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
- Dapagliflozin (S)-propylene glycol hydrate
- Dapagliflozin Propylene Glycolate Hydrate
- Edistride
- Farxiga
- Forxiga
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol (1:1), monohydrate
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (1:1) monohydrate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 14 products.
Dapagliflozin Propanediol
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C21H25ClO6·C3H8O2·H2OColor and Shape:White Off-White PowderMolecular weight:502.19696Dapagliflozin ((2S)-1,2-propanediol, hydrate)
CAS:Dapagliflozin ((2S)-1,2-propanediol, hydrate)Formula:C24H35ClO9Purity:≥98%Molecular weight:502.98D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
CAS:Formula:C24H35ClO9Purity:99%Color and Shape:SolidMolecular weight:502.9823Ref: IN-DA00IMNP
1kgTo inquire5kgTo inquire100mg26.00€1g27.00€250mg30.00€5g40.00€25g84.00€100g208.00€500g688.00€Dapagliflozin Propanediol Hydrate
CAS:Dapagliflozin Propanediol HydrateFormula:C24H35ClO9Purity:99%Molecular weight:502.98Dapagliflozin ((2S)-1,2-propanediol, hydrate)
CAS:(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (S)-propane-1,2-diol hydrateFormula:C24H35ClO9Purity:99%Molecular weight:502.98Dapagliflozin propanediol monohydrate
CAS:Formula:C21H25ClO6·C3H8O2·H2OPurity:≥ 98.0%Color and Shape:White to yellow or beige powder or solidMolecular weight:502.98Dapagliflozin (2S)-1,2-Propanediol Monohydrate
CAS:Formula:C21H25ClO6·C3H8O2·H2OColor and Shape:NeatMolecular weight:502.98Dapagliflozin ((2S)-1,2-propanediol, hydrate)
CAS:Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) is a selective, orally active inhibitor of the renal sodium-glucose co-Formula:C24H35ClO9Purity:99.88% - 99.94%Color and Shape:SolidMolecular weight:502.98Dapagliflozin Propanediol Monohydrate
CAS:Formula:C21H25ClO6C3H8O2H2OMolecular weight:408.88 : 76.09 : 18.0(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL COMPOUND WITH (S)-PROPANE-1,2-DIOL (1:1) HYDRATE
CAS:Purity:95%Molecular weight:502.989990234375Dapagliflozin Propanediol Hydrate
CAS:Formula:C21H25ClO6·C3H8O2·H2OColor and Shape:NeatMolecular weight:502.98Dapagliflozin propanediol monohydrate - Bio-X ™
CAS:Dapagliflozin is a sodium-glucose cotransporter subtype 2 (SGLT2) inhibitor that can be used in the treatment of diabetes mellitus type 2. It inhibits glucose reabsorption in the proximal tubule of the nephron and results in glycosuria, which helps to improve glycaemic control. Also, Dapagliflozin is used to lower the risk of sustained eGFR decline, end-stage renal disease, cardiovascular death, and hospitalization for heart failure in patients with chronic kidney disease who are at risk of progression.Formula:C21H25ClO6•C3H8O2•H2OPurity:Min. 95%Color and Shape:PowderMolecular weight:502.98 g/molDapagliflozin propanediol monohydrate
CAS:Dapagliflozin is an oral antidiabetic drug that acts by inhibiting the SGLT2 enzyme. The SGLT2 enzyme is responsible for reabsorbing glucose from the kidney, so by inhibiting this enzyme, glucose will be excreted in the urine and blood glucose levels will decrease. Dapagliflozin also has a low bioavailability in vivo, which can be improved by administration with food. This drug has been shown to have a longer elimination half-life than canagliflozin and empagliflozin. Dapagliflozin has been shown to have a higher potency than metformin hydrochloride in vitro.Formula:C24H35ClO9Purity:(Hplc) Min. 99.0%Color and Shape:PowderMolecular weight:502.98 g/mol
![D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA00IMNP.jpg&w=3840&q=75)
